RMS partners with M42 to enhance heart and lung transplant services

As part of an official visit to the United Arab Emirates, a delegation from Bahrain’s Royal Medical Services (RMS), led by Brigadier General Dr. Shaikh Fahad bin Khalifa bin Salman Al Khalifa, Commander of the RMS, attended the 50th edition of the Arab Health Conference and Exhibition.

During the visit, RMS signed a partnership with M42, a leading healthcare company, to facilitate heart and lung transplants for patients in Bahrain, ensuring adherence to top international standards.

As part of this collaboration, RMS signed its first memorandum of understanding (MoU) with M42 to support heart and lung transplants in alignment with Abu Dhabi’s national organ donation and transplantation programme, Hayat. The MoU was signed during a meeting at Arab Health by Brig. Gen. Dr. Shaikh Fahad bin Khalifa and Hasan Jassim Al Nowais, Managing Director and Group CEO of M42 and Chairman of Cleveland Clinic Abu Dhabi.

Under the agreement, Cleveland Clinic Abu Dhabi, part of M42, will provide specialised transplant services through its Organ Transplant Centre, the UAE’s only multi-organ transplant facility. Since its establishment in 2017, the centre has performed over 664 transplants, including 311 in the first half of this year. It has also been recognised by the Department of Health – Abu Dhabi as a centre of excellence for adult cardiac surgery.

This partnership will enable Bahraini patients to benefit from RMS’s advanced medical capabilities alongside Cleveland Clinic Abu Dhabi’s expertise in heart and lung transplantation.

The strategic partnership between RMS and M42 aims to enhance medical excellence through high-quality education, knowledge exchange, and fellowship programmes. It also focuses on advanced laboratory diagnostics, including genomics, joint research, and improving clinical care in complex medical fields.

Scroll to Top